It has been revealed that IL-10 level was positively correlated with MDSCs expansion and tumor progression in patients with anaplastic thyroid cancer, ovarian cancer, gastric cancer and no-small cell lung cancer (Suzuki et al., 2013; Li et al., 2015; Pogoda et al., 2016; Wu et al., 2017). This evidence concerns the gene IL10 and ovarian cancer.